quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:05:00·3d
PRRelease
Trevi Therapeutics Inc. logo

Trevi Therapeutics Announces Closing of $173 Million Underwritten Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares

TRVI· Trevi Therapeutics Inc.
Health Care
Original source

Companies

  • TRVI
    Trevi Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Nov 13UpdateLeerink Partners$13.00
  • Aug 21UpdateMorgan Stanley$18.00
  • Jul 1UpdateCantor Fitzgerald$25.00
  • May 28UpdateH.C. Wainwright$21.00
  • Mar 10UpdateRaymond James$29.00
  • Mar 10UpdateNeedham$25.00

Related

  • PR19h
    Trevi Therapeutics to Participate in Upcoming May Events
  • SEC2d
    SEC Form DEF 14A filed by Trevi Therapeutics Inc.
  • SEC2d
    SEC Form DEFA14A filed by Trevi Therapeutics Inc.
  • SEC6d
    SEC Form 424B5 filed by Trevi Therapeutics Inc.
  • SEC7d
    Trevi Therapeutics Inc. filed SEC Form 8-K: Other Events
  • PR7d
    Trevi Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock
  • SEC7d
    SEC Form 424B5 filed by Trevi Therapeutics Inc.
  • PR7d
    Trevi Therapeutics Announces Proposed Public Offering of Common Stock
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022